Retrospective Study of the Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Post-hepatitis C Cirrhosis
Phase of Trial: Phase IV
Latest Information Update: 12 Mar 2018
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Peginterferon alfa-2a; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Mar 2018 Status changed from recruiting to completed.
- 12 Nov 2017 Planned number of patients changed from 1000 to 6000.
- 16 Dec 2016 New trial record